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Abstract
Background: Oxidative stress (OS) is an important factor in brain aging and neurodegenerative
diseases. Certain neurons in different brain regions exhibit selective vulnerability to OS. Currently
little is known about the underlying mechanisms of this selective neuronal vulnerability. The
purpose of this study was to identify endogenous factors that predispose vulnerable neurons to OS
by employing genomic and biochemical approaches.
Results: In this report, using in vitro neuronal cultures, ex vivo organotypic brain slice cultures and
acute brain slice preparations, we established that cerebellar granule (CbG) and hippocampal CA1
neurons were significantly more sensitive to OS (induced by paraquat) than cerebral cortical and
hippocampal CA3 neurons. To probe for intrinsic differences between in vivo vulnerable (CA1 and
CbG) and resistant (CA3 and cerebral cortex) neurons under basal conditions, these neurons were
collected by laser capture microdissection from freshly excised brain sections (no OS treatment),
and then subjected to oligonucleotide microarray analysis. GeneChip-based transcriptomic
analyses revealed that vulnerable neurons had higher expression of genes related to stress and
immune response, and lower expression of energy generation and signal transduction genes in
comparison with resistant neurons. Subsequent targeted biochemical analyses confirmed the lower
energy levels (in the form of ATP) in primary CbG neurons compared with cortical neurons.
Conclusion: Low energy reserves and high intrinsic stress levels are two underlying factors for
neuronal selective vulnerability to OS. These mechanisms can be targeted in the future for the
protection of vulnerable neurons.
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Background
Oxidative stress (OS) is an important factor in brain aging
and some neurodegenerative diseases [1-4]. Under nor-
mal conditions, the processes of generating and scaveng-
ing reactive oxygen (ROS) and nitrogen species (RNS) are
in equilibrium. Excessive production of ROS or RNS leads
to oxidative modification and altered functional states of
proteins, nucleic acids, and lipids. During aging and in
certain diseased states, this equilibrium is disrupted and
selectively affects neuronal survival in specific brain
regions. The selective effects of OS on neurons are mani-
fested as cell death in restricted populations of neurons
while many other neurons appear to cope with the stress
induced by excess ROS or RNS production [5-8]. Selective
neuronal vulnerability (SNV), such as that seen following
OS, has also been observed following other brain insults,
for example, glutamate excitotoxicity, ischemia, or β-amy-
loid-induced neurotoxicity [9-13]. In order to shed more
light on SNV in general, transcriptomic analyses of neu-
rons that exhibit differential vulnerability to various
insults or to the damage brought about by neurological
diseases have been performed in human and rodent hip-
pocampus and human midbrain dopaminergic neurons
[14-19]. However, none of these studies except for the one
on dopaminergic neurons focused on a specific form of
stress, or on genes or bio-functions that might contribute
to the etiology of SNV.
It is important to note that a common pathway to neuro-
nal injury resulting from the various forms of brain insult
mentioned above is believed to be that of induction of
intracellular OS. Yet, there is currently little information
on the mechanisms for SNV to OS. Since OS-sensitive
neurons might be the ones that degenerate early during
the aging process or in certain neurodegenerative diseases
[1], study of the molecular mechanisms of SNV to OS may
offer insights into both aging-associated and disease-initi-
ated neurodegeneration, as well as provide leads to the
protection of vulnerable neurons. To study the relation-
ship between SNV and OS, we thought it necessary to
determine differences in the redox status and OS-han-
dling capacity of both OS-sensitive and OS-resistant neu-
rons. In a previous study, we found molecular indications
of an intrinsically high level of oxidative activity under
baseline conditions in OS-vulnerable CA1 when com-
pared with OS-resistant CA3 neurons in organotypic cul-
tures maintained in vitro [20]. In a subsequent study, we
examined how neurons in CA1 and CA3 responded differ-
entially to OS increases in terms of the neuronal gene
expression patterns and we identified genes whose expres-
sion distinguished the responses of CA1 from those of
CA3 neurons [21]. Since our previous studies were per-
formed on neurons maintained in vitro in organotypic cul-
tures, the patterns of gene expression might not have been
identical to those of neurons in the intact brain in vivo.
Furthermore, in order to advance our understanding of
mechanisms of SNV to OS, it was considered important to
probe for differences between vulnerable and resistant
neurons extracted from several brain regions besides the
hippocampus pyramidal neuron layers, and to do so with
neurons in their native states.
The identification and inclusion of more than two neuro-
nal populations that are either susceptible or resistant to
OS should help in revealing more generalized patterns of
gene expression associated with SNV. This was thought to
be the case as some of the results obtained from compar-
ative analyses of only CA1 vs. CA3 may simply reflect
regional or ontogenetic differences between these two
neuronal populations rather than selective vulnerabilities
to stressors like OS. In initial studies described in this
paper, we found that cerebellar granule (CbG) cells were
a group of cells that were quite vulnerable to OS, whereas
neurons from the cerebral cortex were relatively resistant.
Based on these observations, we included both cortical
and CbG neurons to our genomic and biochemical inves-
tigations of SNV. In order to identify endogenous predis-
posing factors that may lead to the selective vulnerability
of CA1 and CbG neurons to OS, we employed laser cap-
ture microdissection (LCM) to collect these target neurons
from freshly prepared brain sections under basal condi-
tions (no OS induction), and compared their transcrip-
tomic profile with that of the CA3 and cortex neurons.
Following the findings obtained from the functional
genomics study, targeted biochemical analyses on key
antioxidant enzymes and ATP generation were carried
out.
Results
CbG as well as CA1 neurons exhibit vulnerability to OS
We first attempted to determine if primary neuronal cul-
tures of CbG and cerebral cortical cells were differentially
sensitive to OS. Despite the caveat that studies performed
with neurons grown in vitro may not reflect exactly the
responses of neurons in vivo, primary neuronal cultures
were used in these studies because they are composed of
approximately 90–95% neurons. Thus, differential
responses to OS could be directly attributed to specific
characteristics of neurons from these two brain regions.
Oxidative stress was induced by exposing the neuronal
cultures to various concentrations of paraquat (0–50 μM).
Paraquat induces OS by generating superoxide in neurons
through the process of one-electron reduction by the fla-
voenzyme NADPH-cytochrome P450 reductase [22-25].
Increases in paraquat concentration led to a dose-depend-
ent increase in cell death in both types of neurons, but the
effect of paraquat on neuronal survival was greater for
CbG than cerebral cortical neurons. For example, treat-
ment with the highest concentration of paraquat (50 μM)
caused approximately 80% neuronal death in CbG but
40% in cerebral cortical neurons (Fig. 1A). Two-way
ANOVA indicated that the effect of paraquat treatment onBMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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survival in the two types of cells was statistically signifi-
cant (df = 4, F = 42.822, P < 0.001). The viability of CbG
neurons was significantly lower than that of cortical neu-
rons across all paraquat concentrations (t-test, P values <
0.001).
Since oxygen (O2) tension in the ambient air surrounding
the medium of primary neuronal cultures is ~20% (by
volume), i.e., higher than that in the body, an important
difference between neurons in culture as compared with
those in the intact brain may be the fact that primary neu-
rons in culture are continuously exposed to high O2 con-
centrations and, possibly, some level of OS. Thus, the
effects of paraquat on cell viability of primary neurons
might have been a combined effect of exposure of these
neurons to increased O2 tension and to paraquat. In order
to determine whether different levels of O2 tension, in the
absence of an ROS-generating chemical agent, were asso-
ciated with differential neuronal viability, we compared
neuronal survival over 21 days in vitro (DIV) for neurons
in cultures maintained under either reduced (5%) or high
O2 (20%) atmosphere. While high O2 tension had no sig-
nificant effect on the survival of cerebral cortical neurons
grown in culture for 7 and 14 DIV when compared with
survival in low O2 tension, the survival of cortical neurons
grown for 21 days under reduced O2 tension (5% O2)
exhibited significantly higher survival than neurons
grown for 21 DIV under high O2 (20% O2) tension (Fig.
1B). The effect of high O2 tension on the survival of CbG
neurons was greater than that on cerebral cortical neu-
rons. CbG neurons grown for either 14 or 21 DIV under
5% O2 tension had significantly higher survival than those
grown under 20% O2 tension (Fig. 1C). Two-way ANOVA
testing the effects of neuronal type and O2 tension on cell
viability showed that, overall, cortical neurons had signif-
icantly higher viability than CbG neurons (df = 1, F =
8.646, P = 0.006). Three-way ANOVA testing time of expo-
sure, O2 tension, and cell type showed significant interac-
tions (all P values < 0.001). Post-hoc analyses using the
Holm-Sidak method indicated significant effects of time
of exposure (df = 2, F = 130.825, P < 0.001), O2 tension
(df = 1, F = 27.296, P < 0.001), and cell type (df = 1, F =
79.106, P < 0.001) on cell viability. These data demon-
strated that, even in the absence of agents that generate
intracellular ROS, CbG neurons were more sensitive to
changes in environmental O2 tension than cortical neu-
rons.
The conditions of primary cultures of cerebral cortical
neurons differed from those used in primary cultures of
CbG neurons and may thus have affected the overall
response of these two types of neurons to paraquat-
induced OS. In order to determine the effects of OS under
uniform conditions of cell growth and maintenance in
vitro, we also examined the effects of paraquat on neuro-
nal viability in organotypic slice cultures of cerebral cortex
and cerebellum. The conditions of growth of slice cultures
were the same for both cortical and cerebellar cultures.
Organotypic slice cultures would also allow us to deter-
mine if the differential vulnerability of CbG and cortical
neurons observed in primary neuronal cultures would be
observed in brain sections that contain both neurons and
glia. Organotypic slice cultures maintain a relatively nor-
mal brain cyto-architecture while cells are growing in cul-
ture. Such cultures were previously used by us and others
to document the differential vulnerability to OS of hip-
pocampus neurons of the CA1 and CA3 regions [5,20]. In
these previous studies, the superoxide-generating agent
employed was duroquinone. But, in the present studies,
the investigations were expanded to include a different
agent whose metabolism leads to superoxide formation,
paraquat, and thus assess whether the cell death produced
was related to the common property of these two chemi-
cal agents, i.e., superoxide generation in cells.
In the present study, we employed organotypic slice cul-
tures of cerebral cortex, cerebellar cortex, and hippocam-
pus, including the CA1 and CA3 regions, all grown and
exposed to either paraquat or vehicle under identical con-
ditions. But, since the intent was to obtain neurons from
freshly prepared brain slices for the purpose of transcrip-
tomic analyses, i.e., fresh tissue at near in vivo conditions,
we also examined the effects of paraquat on neuronal via-
bility in hippocampus, cerebral and cerebellar cortex in
acute brain slice preparations. The acute slice preparations
were obtained from adult rats whereas those maintained
in vitro for prolonged periods were obtained from 6–7
day-old pups. In the slice cultures maintained under pro-
longed incubation conditions in vitro, paraquat (final con-
centration 100 μM) was applied to the brain slices after
they were in culture for one week and the effects on neu-
ronal survival assessed 24 h after exposure to paraquat or
vehicle. In the case of acutely prepared slices, the slices
were incubated in culture medium for only a period of
two hours before the same paraquat treatment. Although
the cell survival rate was lower, in general, in cultures
established from adult animals in comparison to those
from young pups, greater neuronal death following
paraquat exposure was observed in the CA1 and CbG
regions as compared with the CA3 and cerebral cortex,
and that was the case in both prolonged organotypic slice
cultures and acute slice preparations (Fig. 2). Thus, in
terms of sensitivity to OS, CbG neurons were similar to
CA1 hippocampus neurons, whereas cortical neurons
were similar to CA3 neurons. The presence of glial cells in
slice cultures did not seem to alter the relative vulnerabil-
ity of CbG and cortical neurons to OS.
Comparative biochemical analyses of CbG and cerebral 
cortical neurons
The observed differential sensitivity of CbG and cortical
neurons to paraquat and superoxide-induced OS, regard-BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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Effect of paraquat and of differential levels of oxygen tension on the viability of primary CbG and cerebral cortical (CTX) neu- rons Figure 1
Effect of paraquat and of differential levels of oxygen tension on the viability of primary CbG and cerebral cor-
tical (CTX) neurons. (A) Effects of paraquat on neuronal viability. Both types of neurons were exposed to the indicated con-
centrations of paraquat for 24 h at 37°C. Cell viability was determined by the calcein AM and PI labeling method. Data 
represent the mean (± SEM) of neuronal viability from 10 experiments. The P values from Student's t-test are shown for the 
indicated comparisons. (B, C) Survival of neurons across days in vitro (DIV) under different levels of oxygen (5% and 20%). Via-
bility of neurons was measured by the MTT assay. The data represent the mean (± SEM) from 3 experiments. Statistically sig-
nificant differences (t-test) are shown for the indicated comparisons.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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less of the culture type, culture conditions, or the relative
chronicity of in vitro incubation of the cultures, afforded a
good opportunity to conduct preliminary studies to deter-
mine whether differences in either the metabolism of
paraquat or in the handling of superoxide by neurons
might account for the differential vulnerabilities between
these two neuronal populations. As mentioned above,
paraquat generates superoxide anions through one-elec-
tron transfer reactions catalyzed by NADPH-cytochrome
P450 reductase. Therefore, we first focused on potential
differences in the levels of NADPH-cytochrome P450
reductase between CbG and cortical neurons. The protein
levels of this enzyme were higher in cerebral cortical than
CbG neurons (Fig. 3A). Based on these observations, it
might have been expected that cortical neurons would be
more susceptible to superoxide generation than CbG neu-
rons. However, this was not the case. Thus, enhanced
superoxide formation by cytochrome P450 reductase
could not account for the greater sensitivity of CbG neu-
rons to OS.
We next considered the possibility that the vulnerable
neurons expressed lower levels of key anti-oxidant
enzymes. Cu/Zn-SOD (SOD1), Mn-SOD (SOD2) and
glutathione peroxidase (GPX1), were selected as oxidore-
ductases whose differential levels of expression might
determine differential vulnerabilities to OS. The levels of
SOD1 and GPX1 did not differ significantly between cere-
bral cortical and CbG neurons (Fig. 3B). However, the
protein levels of SOD2 were 2.5 times higher in CbG than
cortical neurons (Fig. 3B). Thus, based on endogenous
SOD2 levels, it might have been predicted that CbG neu-
rons would be more resistant than cortical neurons, which
was not the case. It is possible that because these studies
were performed using primary cultures maintained at
20% oxygen atmosphere, the elevated SOD2 levels in
CbG neurons might have reflected an enhanced response
of these neurons to OS induced that might have been
induced by the high O2 tension present under the culture
conditions used.
To determine if exposure of cerebral cortical and CbG
neurons to OS that was produced through increased
superoxide generation could affect the expression of the
three oxidoreductases, the levels of SOD1, SOD2, and
GPX1 were measured in neurons treated with paraquat
(Fig. 3C). Statistical analyses showed that the levels of
SOD1 were not significantly altered following treatment
of either CbG or cortical neurons with paraquat. However,
the levels of both SOD2 and GPX1 were significantly
increased in CbG but not cortical neurons following expo-
sure to paraquat. Results of two-way ANOVA indicated
that SOD2 content was in general significantly higher in
CbG vs. cerebral cortical neurons (df = 1, F = 113.958, P <
0.001). Therefore, the higher levels of SOD2 in CbG as
compared with cortical neurons grown in primary cul-
tures could reflect an adaptive response to exposure to ele-
vated levels of O2 tension and the resulting OS.
Overall, these results indicated that the OS-vulnerable
CbG neurons had the capacity to respond to increases in
OS through the expression of higher SOD2 levels as com-
Selective vulnerability of hippocampal CA1 and CbG neurons as compared with CA3 and CTX neurons in organotypic brain  slice cultures and in acute slice preparations Figure 2
Selective vulnerability of hippocampal CA1 and CbG neurons as compared with CA3 and CTX neurons in 
organotypic brain slice cultures and in acute slice preparations. Both organotypic brain slice cultures and acute slice 
preparations were treated with paraquat (100 μM, 1 h). Cell survival was determined by PI labeling. Data represent the mean ± 
SEM. The number of experiments were n = 6 for (A) and n = 3 for (B). Statistically significant differences (t-test) are shown for 
the indicated comparisons.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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Protein levels of NADPH-cytochrome P450 reductase and for cellular oxidoreductases in CTX and CbG neurons Figure 3
Protein levels of NADPH-cytochrome P450 reductase and for cellular oxidoreductases in CTX and CbG neu-
rons. (A) Protein levels of NADPH-cytochrome P450 reductase in neurons. Immune labeling with anti-cytochrome P450 
reductase antibodies was performed on proteins extracted from neurons cultured under conditions of 20% O2 tension. Results 
of densitometric measurements of the immuno-reactive band in each immunoblot are shown as the mean (± SEM) of 5 exper-
iments. Statistically significant differences (t-test) are shown for the indicated comparisons. (B) Protein levels of SOD1, SOD2, 
and GPX1 in neurons. Immune labeling with anti-SOD1, anti-SOD2, and anti-GPX1 antibodies was performed on proteins 
extracted from neurons cultured as described in A. Results of densitometric measurements of the immuno-reactive bands in 
each immunoblot are shown as the mean (± SEM) of 3 experiments. Statistically significant differences (t-test) are shown for 
the indicated comparisons. (C) Effect of paraquat-induced OS on the protein levels of SOD1, SOD2, and GPX1 in neurons. Pri-
mary neurons in culture were exposed to the indicated concentrations of paraquat for 24 h at 37°C. Immune labeling with anti-
bodies was performed as described in B. Results of densitometric measurements of the immuno-reactive bands in each 
immunoblot are shown as the mean (± SEM) of 3–5 experiments. Statistically significant differences (t-test) are shown for the 
indicated comparisons.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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pared with cortical neurons. Furthermore, CbG neurons
showed much greater up-regulation of GPX1 than did cer-
ebral cortical neurons following exposure to paraquat.
This would suggest that CbG neurons would be equally or
more protected from OS-induced cell death than cortical
neurons. In conclusion, CbG neurons neither had
reduced capacity to generate superoxide from paraquat
nor reduced levels of anti-oxidant enzymes that protect
neurons from OS. These relatively straightforward expla-
nations of possible mechanisms of differential vulnerabil-
ities of neurons to OS failed to reveal a pathway that
might account for these differential properties of neurons.
For this reason, the subsequent studies were focused on a
more global approach to characterization of differentiat-
ing molecular pathways among the neurons derived from
each of the four regions of rat brain that exhibited differ-
ential susceptibility to OS.
Comparative transcriptome analyses of OS-vulnerable and 
OS-resistant neurons under basal conditions
In order to obtain a global view of molecular processes
that might predispose CA1 and CbG neurons to greater
sensitivity to OS compared with CA3 and cerebral cortical
neurons, we performed transcriptomic analyses of neu-
rons from these four brain regions. These studies were per-
formed under basal conditions, i.e., no paraquat-induced
exogenous OS. In order to minimize non-target noise that
might result from variations in sample collection and
preparation, we employed LCM for the collection of
highly homogeneous neuronal populations [26,27]. The
homogeneity in the neuronal populations collected from
the four designated brain regions is shown in the repre-
sentative sections in Fig 4A. The cryosections used for
LCM were prepared from rat brains frozen immediately
after sacrifice, thus preserving, as much as possible, their
native state in the brain and allowing us to assess the
molecular differences among neurons under conditions
that are likely to exist in vivo. The conditions for LCM dis-
section and recovery of neurons from the four brain
regions were similar to those employed in the preparation
of the acute adult brain slices that were used to detect the
differential responses of neurons to paraquat-induced OS.
Thus, uncovering differences under basal, near in vivo con-
ditions, in the transcriptomic patterns between neurons
that were vulnerable and those that were resistant to OS,
might be indicative of the molecular pathways that are
involved in determining the differential sensitivities to
OS. Because the transcriptomic analyses planned were
focused on differences detected under basal conditions,
the rats used in the microarray studies were not subjected
to any treatment that would induce OS.
Excellent reproducibility among replicate samples in
GeneChip analysis was achieved. Non-target, systematic
noise was very low. The mean correlation coefficient
LCM of neurons from the pyramidal cell layers of CA1 and  CA3 of hippocampus, CbG cells of cerebellum, and layers IV- VI of cerebral cortex, and condition tree and Principal Com- ponents Analysis of microarray data from the captured neu- rons Figure 4
LCM of neurons from the pyramidal cell layers of 
CA1 and CA3 of hippocampus, CbG cells of cerebel-
lum, and layers IV-VI of cerebral cortex, and condi-
tion tree and Principal Components Analysis of 
microarray data from the captured neurons. (A) LCM 
capture of neurons from the four brain regions. The upper 
row shows the lightly stained populations of neurons in the 
respective brain sections, the middle row shows the image of 
the sections after neuronal capture by LCM, and the bottom 
row shows the captured neurons on the LCM cap. (B) Con-
dition tree analysis of microarray data. Condition tree analy-
sis was based on expression values of all probesets on the 
Affymetrix RAE230A GeneChip (color bar shown at right 
indicates relative gene expression levels). Pearson correla-
tion was used as measurement of similarity. (C) PCA of 
microarray data. This analysis allowed for the visualization of 
the relationships among samples from the four brain regions.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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between replicate chips was 0.96 (range 0.91–0.99). Con-
dition Tree and Principal Components Analysis (PCA)
further supported the high reproducibility and low noise
achieved in these studies (Fig. 4B, C). These analyses were
based on genome-wide gene expression profiles and
showed that samples from each brain region formed a
cluster distinguishable from those from the other regions,
regardless of the experimental animal from which the
neurons were derived. This pattern indicated that each
homogeneous neuronal population, e.g., the CA1 region
neuronal population, had its own distinct transcriptome
profile.
For the planned comparative transcriptome analyses,
however, we were interested not in the distinguishing
characteristics between one neuronal population and
another, as such studies have been performed previously
[14-20], but in those characteristics that defined vulnera-
bility vs. resistance to OS. Therefore, we classified the neu-
ronal samples into two groups, i.e., neurons vulnerable to
OS (CA1 hippocampus and CbG neurons) and those
resistant (CA3 hippocampus and cerebral cortex neu-
rons). This approach was expected to focus the analyses of
differential gene expression on the common characteris-
tics that might determine sensitivity to OS. Based on the
volcano plot analysis shown in Fig 5, there were 994 genes
that were differentially expressed in OS-vulnerable as
compared with OS-resistant neurons (t-test P ≤ 0.05 and
fold difference ≥ 1.5). After adjusting for multiple testing,
the Benjamini and Hochberg False Discovery Rate was
0.09. Of the 994 genes, 481 were expressed at significantly
higher levels in the OS-resistant neurons (region "A" of
Fig. 5), while 513 genes were expressed more highly in
OS-vulnerable neurons (region "B" of Fig. 5). Additional
file 1 [see Additional file 1] lists the subpopulation of
genes in the volcano plot whose expression was ≥ 2.0-fold
in vulnerable as compared with resistant neurons, or the
reverse. Uncharacterized genes were not included in Addi-
tional file 1.
In an effort to confirm that the identified genes were a
core set of genes whose expression under basal conditions
could differentiate between neurons vulnerable and those
resistant to OS, an alternative target-gene identification
approach was performed. In this alternative approach, we
compared gene expression profiles between CA1 and CA3
and identified differentially expressed genes between
them. Likewise, gene expression data generated from CbG
and cerebral cortical neurons were also compared and dif-
ferential gene expression patterns between them were
identified. A comparison of convergent genes from the
two independent comparisons and the target genes iden-
tified using the group-based approach described above
(i.e., the 481 genes expressed at higher levels in resistant
neurons and the 513 at higher levels in vulnerable neu-
rons) revealed the following: a) 91% of the 481 resistant-
neuron-higher genes (a total of 437) were convergent
genes that were expressed at higher levels in CA3 and cor-
tex in the two independent comparisons; and b) 94% of
the 513 vulnerable-neuron-higher genes (a total of 484)
were convergent genes that were expressed at higher levels
in CA1 and CbG neurons in the two independent compar-
isons. These findings suggested that the target genes iden-
tified from our group-based approach can be used to
differentiate neurons vulnerable to OS from those that are
resistant with a high degree of accuracy.
In order to evaluate the potential functional differences
between OS-resistant and OS-vulnerable neurons, we per-
formed a comparative analysis on key biological functions
associated with the two lists of genes that were expressed
more highly either in OS-vulnerable or OS-resistant neu-
rons. The Core Comparison Analysis module in the Inge-
nuity Pathways Analysis (IPA) package allowed us to gain
an overview of key differences between the two types of
neurons in terms of their respective gene transcriptomes
(Fig. 6). Overall, neurons in the vulnerable group showed
higher transcriptional activity for genes related to gene
expression, nucleic acid damage repair, RNA trafficking
and post-transcriptional modification, and immune
response, while those in the resistant group had higher
Identification of differentially expressed genes (orange  colored) between the vulnerable (VUL) and resistant (RES)  groups by volcano plot Figure 5
Identification of differentially expressed genes 
(orange colored) between the vulnerable (VUL) and 
resistant (RES) groups by volcano plot. The Y-axis dis-
plays the negative log (base 10) of P values from paired t-
tests, while the X-axis shows the log (base 2) of the -fold dif-
ferences between the two groups (VUL/RES). The blue line 
represents the P = 0.05 value, and the red lines correspond 
to fold differences of 1.5 and -1.5, respectively. Genes with 
paired t-test P < 0.05, and fold difference ≥1.5 or ≤-1.5, were 
identified as differentially expressed genes and are highlighted 
in orange.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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activities in cell signaling, cell function and maintenance,
lipid metabolism, and energy production.
We subsequently conducted a series of in-depth bioinfor-
matic analyses of the genes that were differentially
expressed in the two populations of neurons. The first of
these was the Gene Ontology (GO) characterization, i.e.,
the determination of biological processes, molecular
functions, and cellular components linked to groups of
genes with differential expression patterns [28]. In this
study, we used a statistical model based on the hypergeo-
metric distribution implemented in MAPPFinder [29].
GO terms enriched with genes which were differentially
expressed in vulnerable and resistant neurons are shown
in Table 1. A close examination of the results from this
analysis and a comparison with those of the IPA analysis
showed that there were many common biological func-
tions or processes identified by the two types of analyses.
The major functional groups identified by the GO analy-
ses among genes expressed more highly in vulnerable as
compared with resistant neurons were: 1) DNA repair and
response to DNA damage; 2) Regulation of transcription;
and 3) Intramolecular oxidoreductase activity. The GO
category of regulation of transcription included a tran-
scription factor that functions as a sensor of hypoxia,
hypoxia-inducible factor 1 (Hif1), a glucocorticoid recep-
tor, nuclear receptor subfamily 3/group c/member 1
(Nr3c1), that controls inflammatory responses in cells,
and a transcriptional co-activator of steroid receptors,
Rnpc2. In addition, one of the transcription factors that
transactivates Nr3c1, the POU family homeodomain tran-
scription factor Pou2f1 [30], was also expressed at higher
levels in vulnerable compared with resistant neurons, pos-
sibly indicating the importance of inflammatory
responses and glucocorticoid receptor signaling in OS-
vulnerable neurons. One transcription factor shown in
Table 1, chromobox 7 (Cbx7), and another listed in Addi-
tional file 1 as more highly expressed in OS-vulnerable
neurons, MAD homolog 5 (Smad5), are involved in main-
taining cells in a transcriptionally repressed state and
repressing cyclin-dependent cell cycling [31,32]. Elevated
expression of genes involved in suppression of cell cycling
might be a cell defense against neuronal de-differentiation
and cell death [33]. In the last GO category enriched with
Comparison of transcriptomic profiles between the VUL and RES neurons based on biological functions associated with the dif- ferentially expressed genes identified in each neuronal group Figure 6
Comparison of transcriptomic profiles between the VUL and RES neurons based on biological functions associ-
ated with the differentially expressed genes identified in each neuronal group. The threshold line corresponds to 
the -log value for P = 0.05. Values of significance that is higher than threshold indicate greater numbers of genes, from either 
VUL or RES neurons, associated with the corresponding biological function. For example, although expression of genes related 
to the biological function of "Gene Expression" reached a value of significance above-threshold for both VUL and RES neurons, 
there were many more genes expressed in VUL neurons (54 in total) than the RES neurons (2), thus a higher -log P value for 
VUL than RES.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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genes more highly expressed in vulnerable than resistant
neurons, there were only two genes, protein disulfide-iso-
merase A3 precursor (Pdia3) and emopamil binding pro-
tein (Ebp). Both PDIA3 and EBP are isomerases, both may
control Ca2+ homeostasis in cells, and both are located in
the endoplasmic reticulum (in the lumen or the mem-
brane, respectively) [34,35]. EBP is 3-β-hydroxysteroid-
Δ7-Δ8-isomerase that binds drugs that have anti-ischemic
properties, such as emopamil and ifenprodil [35]. Based
on the differential expression of the genes described
above, the general GO category of stress-defense-response
genes was identified by GO analysis as being more highly
expressed in OS-vulnerable compared with OS-resistant
neurons. This GO category is populated by genes in cate-
gories of "DNA repair", "response to DNA damage stimu-
lus", and "intramolecular oxidoreductase activity". This is
in agreement with the results from the IPA comparative
analysis which identified "DNA damage and repair" and
"immune system development and function" among the
key functions more prevalent in neurons vulnerable to
OS.
The GO categories that contained genes with higher
expression in OS-resistant vs. OS-sensitive neurons were
those of energy generation and carbohydrate metabolism,
as well as action potential, neurotransmission, calcium
signaling, and regulation of signal transduction. Related
GO terms such as "calcium- and calmodulin-dependent
protein kinase activity", "regulation of signal transduc-
tion", "neurotransmitter transport", "synaptic vesicle",
"regulation of neurotransmitter secretion", and "regula-
tion of action potential" were enriched with genes
expressed at higher levels in OS-resistant than OS-vulner-
able neurons. The GO terms "energy derivation by oxida-
tion of organic compounds" and "main pathways of
carbohydrate metabolism" were also enriched with genes
that were expressed at higher levels in resistant as com-
pared with vulnerable neurons. These results matched
some of the key categories identified through the use of
the IPA analysis, in particular, the two major categories of
genes expressed more highly in OS-resistant than OS-vul-
nerable neurons, "cell-to cell signaling and interaction"
and "energy production".
In the present studies, OS-resistant neurons had signifi-
cantly lower transcription levels of genes that fell in the
GO categories of "defense response" (GO:0006952, Z = -
2.14, P = 0.027) and "immune response" (GO:0006955,
Z = -2.037, P = 0.043) compared with OS-vulnerable neu-
rons. These results are not shown in Table 1 as only GO
terms with positive Z scores are included in that table. The
negative Z scores associated with the GO terms "defense
response" and "immune response" might indicate that
either the genes in these two categories were down-regu-
Table 1: Gene Ontology (GO) terms significantly enriched with differentially expressed genes
GO terms and accession numbers Category* Z score Permute P Associated Genes
For genes expressed at higher levels in neurons vulnerable to OS
DNA repair (GO:0006281) BP 4.684 0.001 Hmgb2, Cspg6, Pold1, Tyms, Xab2
Response to DNA damage stimulus 
(GO:0006974)
BP 4.488 0.002 Hmgb2, Cspg6, Pold1, Tyms, Xab2
Regulation of transcription (GO:0045449) BP 2.395 0.011 Cnot2, Cbx7, Cebpe, Ctcf, E2f5, Gmeb2, Hif1a, Nfyc, Nr3c1, 
Pnrc1, Pou2f1, Rere, Rnpc2, Usf2, Zfp57
Intramolecular oxidoreductase activity 
(GO:0016860)
MF 3.165 0.040 Pdia3, Ebp
For genes expressed at higher levels in neurons resistant to OS
Calcium- and calmodulin-dependent protein 
kinase activity (GO:0004685)
MF 5.475 0 Camk2a, Camkk1, Camk1b
Energy derivation by oxidation of organic 
compounds (GO:0015980)
BP 2.839 0.004 Idh3a, Gyg1, Eno1, Pfkp, Ldha, Me1, Idh1
Neurotransmitter transport (GO:0006836) BP 3.313 0.008 Cplx2, Rims2, Slc6a7, Slc6a9, Stx1a
Main pathways of carbohydrate metabolism 
(GO:0006092)
BP 2.739 0.010 Eno1, Pfkp, Ldha, Idh3a, Me1, Idhc
Synaptic vesicle (GO:0008021) CC 2.96 0.012 Sept5, Syn2, Syp, Syt5
Regulation of neurotransmitter secretion 
(GO:0046928)
BP 3.902 0.022 Kcnmb4, Syn2
Regulation of action potential (GO:0001508) BP 3.902 0.022 Kcnmb4, Pllp
Regulation of signal transduction 
(GO:0009966)
BP 2.858 0.025 Igfbp3, Rgs14, Rgs3, Socs2
* BP – Biological Process; CC – Cellular Component; MF – Molecular FunctionBMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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lated in resistant neurons or they were more highly
expressed in vulnerable neurons.
To explore further the biological significance of differ-
ences in gene expression between OS-vulnerable and OS-
resistant neurons, the patterns of differential gene expres-
sion were analyzed to determine the role of such genes in
defined biological pathways. Using a statistical model
similar to the GO analysis, biological pathway analysis
assembles genes (or their corresponding proteins) into
categories of functions that fit certain biological tasks or
processes. Our analysis covered nearly all the currently
known biological pathways deposited in various data-
bases, including the Kyoto Encyclopedia of Genes and
Genomes (KEGG) [36], BioCarta [37] and GenMAPP
[38]. Although this approach is different from that of the
IPA and GO analyses, the results of pathway analysis
(Table 2) showed substantial agreement with those of IPA
and GO analyses.
The pyrimidine metabolism pathway, enriched with
genes expressed more highly in OS-vulnerable compared
with OS-resistant neurons, and the citrate (or TCA) cycle
biological pathway, enriched with genes more highly
expressed in OS-resistant than OS-vulnerable neurons
corresponded, to some extent, to the theme of DNA dam-
age/repair and energy derivation/carbohydrate metabo-
lism shown in Fig 6 and table 1. The biological pathway
analyses, however, revealed some new pathways, such as
the alanine/aspartate metabolism pathway that was
enriched with genes more highly expressed in OS-vulner-
able vs. OS-resistant neurons, and the signal transduction,
prostaglandin synthesis, and actin cytoskeleton regulation
pathways that were enriched with genes expressed more
highly in OS-resistant vs. OS-vulnerable neurons (Table
2). The signal transduction pathways included the MAPK
cascade, Wnt signaling, insulin signaling, and G-protein
signaling pathways. Some of the genes in the biological
pathways listed in table 2 may also be involved in cell sig-
naling and may have a neuroprotective function, for
example, the annexin IV (Anxa4), annexin V (Anxa5), and
annexin VI (Anxa6) genes [39-41].
Pathway analysis identified four genes belonging to the
protein ubiquitination pathway as expressed more highly
in OS-vulnerable than OS-resistant neurons. This pathway
did not reach statistical significance due to the large
number of genes involved. Nevertheless, the four genes
whose expression was high in OS-sensitive neurons, Usp1
(ubiquitin specific peptidase 1, VUL/RES = 10.08, P  =
0.029; VUL: vulnerable group [CbG + CA1], RES: resistant
group [Cortex + CA3]), Usp3 (ubiquitin specific peptidase
3, VUL/RES = 4.63, P = 0.040), Usp48 (ubiquitin specific
peptidase 48, VUL/RES = 1.63, P = 0.001) and Ube2e2
(ubiquitin-conjugating enzyme E2E 2, VUL/RES = 1.54, P
= 0.049), may be indicators of high stress in vulnerable
neurons.
The biological function of energy generation was popu-
lated by genes expressed more highly in OS-resistant than
OS-vulnerable neurons. We performed gene networking
analyses on genes related to cell energy generation using
information from currently available literature data [see
Additional file 2]. This in silico network construct identi-
fied several of the energy-generating genes in the network
that were expressed more highly in neurons from regions
resistant to OS. These genes included Eno1, Idh1, Idh3a,
Ldha, Me1, and Pfkp. Genes that interact with Eno1, Idh1,
Idh3a, Ldha, Me1, and Pfkp were identified by gene net-
working analyses and included Cap1, Egf, Grem1 and
Tgfb1. The function of these five genes is related to cell
development, including differentiation and proliferation,
Table 2: Biological pathways significantly enriched with differentially expressed genes
Biological pathways Z score Permute P Associated Genes
For genes expressed at higher levels in neurons vulnerable to OS
mRNA processing reactome 5.708 0 Cugbp1, Dhx16, Hnrpa1, Hnrpa3, Hnrph1, Hnrpu, Mettl3, Nsep1, Rnpc2, Sfrs3, Sf3b1
Pyrimidine metabolism 3.921 0.008 Nt5e, Pold1, Tyms
Alanine and aspartate metabolism 3.265 0.021 Gpt1, Got2
For genes expressed at higher levels in neurons resistant to OS
MAPK cascade 6.016 0 Araf, Hras, Map2k1, Mapk1, Mapk10, Mbp, Jun
Citrate (or TCA) cycle 3.897 0.006 Acly, Idh1, Idh3a
Regulation of actin cytoskeleton 2.524 0.014 Enah, Fgf13, Fgfr2, Chrm3, Gna12, Hras, Map2k1, Mapk1, Pak3, Pip5k1c, Slc9a1
Prostaglandin synthesis regulation 3.315 0.015 Anxa4, Anxa5, Anxa6, Ptgs2, Hpgd
Wnt signaling 2.882 0.020 Ccnd2, Jun, Mapk10, Prkce, Wnt2b
Insulin signaling 2.136 0.035 Cap1, Gyg1, Hras, Igf1r, Jun, Map2k1, Mapk1, Mapk10, Pten, Sgk
G protein signaling 2.154 0.041 Akap13, Akap6, Gna12, Gng8, Hras1, Prkce, Slc9a1BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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and cell-to-cell signaling and interaction. The gene net-
work analysis suggested a link between energy production
and the high energy demand for cell signaling in OS-
resistant neurons. Direct experimental evidence on differ-
ential levels of energy reserves, i.e., ATP levels, in OS-vul-
nerable and OS-resistant neurons is presented below.
Comparison of gene expression vs. protein levels of SOD1, 
SOD2 and GPX1
The expression of genes for cellular oxidoreductases
known to protect neurons and other cells from OS, i.e.,
those for Sod1, Sod2, or Gpx1, was examined for possible
differential patterns of transcriptional regulation of these
enzymes. The microarray data on Sod1, Gpx1, and Sod2
indicated no significant differences in expression between
CbG and cerebral cortical neurons. The lack of differential
expression of the genes for Sod1 and Gpx1 was anticipated
based on the lack of any differences in SOD1 and GPX1
protein levels between CbG and cerebral cortical neurons
in culture in the absence of added OS stimuli. But,
whereas the protein levels of SOD2 were 2.5 times higher
in CbG compared with cerebral cortical neurons in cul-
tures without the added stimulus of paraquat-induced OS,
the Sod2 gene levels were only marginally higher in OS-
vulnerable compared with OS-resistant neurons captured
from fresh brain sections by LCM (VUL/RES = 1.16, P =
0.063). Thus, the higher protein expression levels of
SOD2 in CbG neurons in culture might have been the
result of exposure of primary neurons to the increased O2
tension in culture.
Confirmation of GeneChip data with real-time 
quantitative PCR
The results of the microarray analyses were validated by
real-time quantitative PCR (qPCR) measurements of the
expression of select genes. These genes were: Nefl, neuro-
filament, light polypeptide; Tf, transferrin; Mt1a, metal-
lothionein 1a; and Nfe2l2  (or  Nrf2), nuclear factor,
erythroid derived 2, like 2. The selection of these genes
was based on two criteria: 1) their expression profiles were
representative of most genes on the array in terms of the
range of transcript abundance levels and expression ratios
between VUL and RES neurons; and 2) the genes were
considered important in terms of differential vulnerability
of cells to OS [20]. For all selected genes, the qPCR data
confirmed the relative expression ratios in VUL vs. RES
neurons (Fig. 7). Among the four genes, three (Mt1a,
Nfe2l2, and Tf) showed similar ratios of expression as
determined by microarray and qPCR. For Nefl, the array
analysis showed a ratio of 0.30 (VUL/RES) whereas the
ratio estimated by qPCR indicated only slightly lower
expression in VUL as compared with RES neurons (VUL/
RES = 0.89). This difference might have been due to the
fact that the targeted gene regions for detection by the two
approaches were different. The GeneChip probe set tar-
geted the last exon (exon 4) of Nefl, while the qPCR anal-
ysis, because of constraints in primer design, targeted
exons 1–2. Despite this difference, the patterns of expres-
sion of the four genes estimated by qPCR were consistent
with those estimated by microarray analyses.
Comparative levels of ATP generation in CbG and cortical 
neurons in primary cultures
The results of genomic analyses indicated that neurons
vulnerable to OS had a lower expression of genes involved
in energy generation. To determine if this would be true in
neurons maintained in culture, we measured the levels of
ATP in primary CbG and cerebral cortical neurons, both
before and after OS induction. The ATP levels of CbG neu-
rons under basal conditions were approximately 25%
lower than those of cerebral cortical neurons, but this dif-
ference was not statistically significant. However, when
exposed to OS, ATP levels in both cell types dropped, but
they did so more precipitously and significantly in CbG
than cortical neurons (Fig. 8). Two-way ANOVA on the
combined data of all paraquat concentrations showed
that, overall, CbG neurons had significantly lower ATP
levels than cortical neurons (df = 1, F = 16.677, P < 0.001).
In addition, the ANOVA results demonstrated that
paraquat had a significant effect on ATP levels (df = 3, F =
9.513,  P  < 0.001). To explore further the relationship
between OS and ATP levels in these two populations of
neurons, we measured changes in the levels of ATP in CbG
and cortical neurons under two different levels of O2 ten-
sion (5% and 20% O2). While the ATP levels in cerebral
cortical neurons were not significantly altered by growing
Validation of microarray data by real-time qPCR Figure 7
Validation of microarray data by real-time qPCR. 
Shown are the average ratios (± SEM, n = 3) of expression of 
the genes Mt1a, Nefl, Nfe2l2, and Tf, in VUL vs. RES neurons 
as measured by GeneChip and qPCR. The qPCR measure-
ments are not significantly different from the GeneChip data 
(P values range: 0.199 – 0.896).BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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them for 7 and 14 DIV under 20% O2 tension, the levels
dropped to significantly lower values (P < 0.05) in neu-
rons maintained for 21 DIV under high O2 tension when
compared with those maintained under 5% O2 (data not
shown). CbG neurons were more sensitive to the different
levels of oxygen and showed significant decreases in ATP
levels at both 14 and 21 DIV for cells exposed to 20% O2
tension compared with those maintained at 5% O2 (P <
0.05 and P < 0.01 for 14 and 21 DIV neurons, respectively;
data not shown). Two-way ANOVA on combined data of
cerebral cortical and CbG neurons demonstrated, once
again, that cerebral cortical neurons had significantly
more ATP than CbG neurons (df = 1, F = 12.089, P =
0.001).
Discussion
Differential sensitivity of neurons to OS was shown in the
present study to be a property of four different neuronal
populations, hippocampal pyramidal neurons from two
adjacent regions, CA1 and CA3, and neurons from two
distant regions of the brain, CbG and cerebral cortex neu-
rons. Selective neuronal vulnerability has been observed
in many previous studies in association with neurodegen-
erative diseases, such as Alzheimer's disease that affects
primarily neurons in the cerebral cortex, hippocampus
and amygdala [42,43], Parkinson's disease that is associ-
ated with the death of dopaminergic neurons of the sub-
stantia nigra [44], and amyotrophic lateral sclerosis that is
related to degeneration of cortical, brain stem and, espe-
cially, spinal motor neurons [45]. In addition, within a
single brain region, such as the human or rodent hippoc-
ampus, selective vulnerability of CA1 vs. CA3 neurons has
been observed following episodes of global cerebral
ischemia [11,46], early phases of Alzheimer's disease [47],
chronic epileptic seizures [48], and OS [5,20]. OS is a
common denominator among these various adverse con-
ditions. For this reason, in the present study, as well as in
our previous studies, we focused on the selective vulnera-
bility of neurons to OS.
There are only a few studies that have compared the sen-
sitivity of CbG to cerebral cortical neurons. Oxygen and
glucose deprivation followed by re-oxygenation revealed
a much greater susceptibility of CbG than cerebral cortical
primary neurons to these stressful conditions, and the
same is true for the toxicity induced by methyl-mercury
treatment of primary neurons [49,50]. Oxygen and glu-
cose deprivation also caused greater suppression of ATP
levels in CbG than cortical cells. The effects of these
manipulations were attributed to a higher sensitivity of
CbG neurons to OS as compared with cerebral cortical
cells. For example, methyl mercury exposure leads to the
generation of higher levels of intracellular ROS in CbG
than in cortical neurons [49] and ischemia/re-oxygena-
tion is known to produce OS. Based on the observations
made in the present study with primary neuronal and
organotypic slice cultures, as well as those in the studies
cited above, there appears to be marked differential sus-
ceptibility of CbG and cerebral cortical neurons to OS. In
the present study, we found that CbG neurons exhibited
significantly lower viability in primary cultures than cere-
bral cortical neurons, even prior to OS treatment. The dif-
ference in neuronal viability between the two populations
of neurons might have been related to an intrinsically
high stress response of CbG neurons. Nevertheless, the
lower survival rate of CbG neurons even in the absence of
OS was not viewed as an invalidation of the findings that
CbG neurons were more vulnerable to OS than cortical
neurons. The differential vulnerability of CbG neurons to
OS induced by paraquat when compared with that of cor-
tical neurons was demonstrated by the fact that the rate of
cell loss was greater in CbG than cerebral cortical neurons
at every paraquat concentration to which the neurons
were exposed (Fig. 1A).
The differences in responses to OS between CbG and cer-
ebral cortical neurons were observed under strong condi-
tions of OS, such as exposure to paraquat (present study),
treatment with methyl mercury [49], or exposure to oxy-
gen-glucose deprivation and re-oxygenation [50], as well
as under milder stimuli of OS, i.e., growth of neurons
under 20% O2 tension. All previous studies comparing
relative CbG and cortical neuron susceptibility to OS were
performed with neuronal cultures maintained under
ambient atmospheric, i.e., 20% O2 tension [49,50]. But, as
we showed in the present study, exposure of CbG neu-
Differential levels of ATP and the effect of paraquat on these  levels in CTX and CbG neurons Figure 8
Differential levels of ATP and the effect of paraquat 
on these levels in CTX and CbG neurons. Data repre-
sent the mean (± SEM) of ATP levels from 8 experiments. 
The P values for the indicated comparisons (t-test) are 
shown.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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rons, in particular, to this level of O2 tension produces cel-
lular OS that leads to reduced survival of neurons in
culture. Future studies examining differences in responses
to OS and the molecular processes that determine differ-
ential sensitivities to OS, should be performed with neu-
rons that were grown under low O2 tension.
Since OS plays an important role in the aging process, the
study of the fate of CbG neurons during the aging process
might be viewed as a model of possible selective vulnera-
bility of these neurons to OS. There is evidence that the
cerebellum granule cell layer undergoes both a loss of
CbG neurons as well as degenerative changes in their
structure as a result of aging. Stereological studies of
human cerebellum have shown that the number of CbG
neurons is significantly decreased (around 40%) in aged
individuals [51,52]. Moreover, there is a notable diminu-
tion of cell volume, axons and synapses in the remaining
neurons [52]. A similar trend has been observed in other
mammalian brains as well [53] and such cell losses and
structural changes may be related to the poor motor coor-
dination, impaired motor learning, and loss of muscular
tone that occur with advancing age.
Our initial studies of protein expression levels in CbG and
cerebral cortical neurons in culture failed to identify a
causal relationship between enzyme levels for cellular oxi-
doreductases and CbG neuron susceptibility to OS. Spe-
cifically, CbG neurons expressed higher levels of SOD2
and GPX1 than cerebral cortical neurons did in response
to increases in OS, yet CbG cells were not better protected
from OS. Whatever molecular differences exist between
these two types of neurons to account for their differential
vulnerability to OS, the differences could not be overcome
by the greater increases in OS-induced SOD2 and GPX1
levels in CbG neurons. These results indicate that it is the
expression of genes and gene products other than general
oxidoreductases that impart either enhanced susceptibil-
ity of CbG cells or increased resistance of cortical neurons
to OS. If this interpretation is valid, then other popula-
tions of OS-vulnerable and OS-resistant neurons, such as
the CA1 and CA3 neurons of the hippocampus, might
exhibit some patterns of gene expression that are similar
to those of CbG and cortical neurons.
The transcriptomic analyses performed on CbG, CA1,
CA3 and cerebral cortical neurons that were captured
from brain sections under basal conditions, revealed that
each neuronal population expressed distinguishable clus-
ters of genes. Nevertheless, by combining the gene expres-
sion patterns of neurons that were shown to be vulnerable
to OS and comparing these patterns to those of neurons
that were resistant to OS, we were able to identify key bio-
logical functions, GO categories and pathways that char-
acterized vulnerable vs. resistant neurons. Importantly,
these differential patterns of gene expression represented
endogenous neuronal differences, not differences brought
about by exposure of these populations of neurons to any
form of OS. The key differences could be summarized as
follows. Neurons that are OS-vulnerable expressed higher
levels than did neurons resistant to OS of genes involved
in cell stress defense, suppression of transcriptional activ-
ity, repair of DNA damage, control of cell cycling, steroid
receptor signaling, and maintenance of intra-endoplasmic
reticulum reducing conditions and Ca2+ levels. On the
other hand, OS-resistant neurons expressed more highly
than OS-vulnerable neurons genes related to neurotrans-
mission, action potential conduction, signal transduction,
and energy generation.
In our previous study of differential responses of CA1 and
CA3 neurons to OS, we observed that during the course of
exposure of neurons to OS, CA1 neurons had consistently
higher expression than CA3 neurons of genes in the cate-
gories of stress/inflammatory response, transition metal
transport, ferroxidase, and presynaptic signaling activity
[21]. On the other hand, CA3 neurons had higher expres-
sion than CA1 neurons of genes in the categories of GABA
signaling, postsynaptic signaling, and calcium and potas-
sium channel activity [21]. The main goal of the present
study was to probe for intrinsic, rather than OS-induced,
biochemical and transcriptional differences between vul-
nerable (CA1 + CbG) and resistant (CA3 + cortical) neu-
rons from four brain regions. Unlike the previous study of
transcriptomic analysis of CA1 and CA3 neurons, there
was no OS applied to the neurons sampled for the tran-
scriptomic analyses, the analyses were extended to neu-
rons from other regions with differential sensitivities to
OS, and the neurons were captured from brain sections as
proximal to the in vivo condition as possible. Neverthe-
less, despite the differences between the conduct of the
two studies, some of the findings from the current study
were in accordance with the results from the previous
study. In the GO analysis, sensitive neurons had higher
transcriptional activity than resistant neurons of stress
response genes; resistant neurons had relatively higher
expression of genes related to signal transduction and
neurotransmission than vulnerable neurons. This consist-
ency indicated that these key transcriptional differences
are potentially good markers in differentiating neurons
that are vulnerable to OS from those that are resistant. At
the level of differences in expression of single genes, of the
31 genes that were more highly expressed in CA3 than
CA1 during induction of OS, 18 were genes that were also
expressed at significantly higher levels in the OS-resistant
vs. OS-vulnerable neurons in the present study (the
known genes are listed in Table 3). Included among these
genes were (also listed in Additional file 1): Nefl, neurofil-
ament light polypeptide; Gabra5,  γ-aminobutyric acid
receptor 5 α;  Rab15, member of Ras  oncogene family;BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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Opcml, opioid binding protein/cell adhesion molecule-
like;  Pllp, plasma membrane proteolipid; Cadps, Ca2+-
dependent secretion activator; Ncald, neurocalcin δ; and
Cacna2d3, calcium channel (voltage gated) α2/δ3 subu-
nit.
Some of the pronounced findings (higher stress and lower
energy production in vulnerable neurons) generated from
the present study of functional genomics, were directly
supported by traditional biochemical data. In our previ-
ous reports, we demonstrated the existence of higher
intrinsic stress and inflammatory response in the vulnera-
ble CA1 neurons [20,21]. The in vitro measurement of
basal superoxide generation in the hippocampal CA1 and
CA3 regions showed that the vulnerable CA1 neurons
generated more superoxide than the resistant CA3 neu-
rons. In the present report, the in vitro measurements of
ATP levels in CbG and cerebral cortical neurons in culture
confirmed the differential levels of energy generation in
these two cell populations.
Furthermore, these studies confirmed previous observa-
tions that the depletion of ATP stores in CbG neurons is
much greater than that in cerebral cortical neurons upon
exposure to OS [50]. To survive stressful conditions, neu-
rons would need readily available sources of energy,
mostly in the form of ATP. ATP is needed for repair or
replenishment of damaged cellular components, such as
DNA and proteins, and for re-establishing ionic gradients.
Studies on the selectively vulnerable dopamine neurons
of the substantia nigra indicate that lower ATP production
and higher OS may be consequences of mitochondrial
dysfunction [54]. Mitochondrial complex I activity in
neurons of the substantia nigra obtained from patients
suffering from the sporadic form of Parkinson's disease is
decreased [55]. Mitochondrial complex I defects may con-
tribute to decreases in ATP synthesis and to excesses in the
production of ROS in nigra neurons. Further support for
the idea that OS-vulnerable neurons may be subjected to
increases in ROS formation throughout their lifespan
comes from observations that mitochondria isolated from
CA1 neurons of the hippocampus release more ROS than
those from neurons of the CA3 region [56].
It is important to point out that four major gene expres-
sion patterns characteristic of neurons vulnerable to OS,
i.e., high stress and immune responses, decreased energy
generation, increased DNA repair, and reduced signal
transduction, are similar to gene expression profiles that
have been observed in cells from aging brain [57-62]. The
increases in expression of some of these genes, for exam-
ple, those related to DNA repair, have been linked to
increases in OS in neurons, to aging-associated neuronal
gene expression, and to DNA damage in genomic DNA of
Table 3: Currently known genes that were more highly expressed in resistant than vulnerable neurons in both the present and 
previous study [21]
Affymetrix_ID Gene Symbol Description Fold Difference (RES/VUL)a t-Test P Valueb
1372953_at Ncald neurocalcin delta 7.90 3.79E-04
1370058_at Nefl neurofilament, light polypeptide 3.28 9.53E-04
1390358_at Cacna2d3 calcium channel, voltage-dependent, alpha 2/delta 3 
subunit
2.91 0.019
1368810_a_at Mbp myelin basic protein 2.33 0.011
1373646_at Rab15 RAB15, member RAS onocogene family 2.17 2.22E-03
1371057_at Gabra5 gamma-aminobutyric acid (GABA-A) receptor, subunit 
alpha 5
2.14 0.019
1368114_at Fgf13 fibroblast growth factor 13 2.13 1.26E-03
1368523_at Cadps Ca2+-dependent secretion activator 1.86 3.31E-03
1386943_at Pllp plasma membrane proteolipid 1.59 0.025
1368861_a_at Mag myelin-associated glycoprotein 1.56 0.024
1387961_at Opcml opioid binding protein/cell adhesion molecule-like 1.50 4.37E-04
a,b – Calculations based on data from this study. Since the previous study [21] was a time-course study, no corresponding data were available.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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cells in the brains of aged individuals as a result of nucle-
otide base oxidation [60,61]. In addition to the increases
in the gene categories described above, there are decreases
in aging brain of genes related to neurotransmission and
signal transduction [61]. The similarities in transcriptome
patterns between neurons that are vulnerable to OS and
those that have gone through the aging process in brain
may indicate that aging-related events enrich the gene
expression patterns that are seen in neurons that are vul-
nerable to OS. Such enrichment of gene expression may
have important adaptive functions for the aging brain,
such as defense against age-associated increases in OS-
induced damage.
Conclusion
Oxidative stress plays an important role in brain aging
and neurodegenerative diseases but not all brain neurons
are equally sensitive to OS. Those that are sensitive to OS
are the first ones to suffer functional decline during aging
or cell death in neurodegenerative diseases. To protect
these vulnerable neurons from age- or disease-associated
injury, the first step to be accomplished is to understand
the molecular mechanisms that underlie the high sensitiv-
ity of certain neurons to OS. However, the molecular
determinants of differential neuronal sensitivity to OS
remain unknown. In this study, the integration of high-
precision target neuron collection by LCM, high-through-
put functional genomics, and more targeted biochemical
analyses were employed to improve our understanding of
SNV to OS. The study of more than one population of sen-
sitive and resistant neurons was deliberately introduced in
order to increase the confidence in the results obtained.
The data provided evidence that high stress levels and low
energy reserves were important predisposing factors of
SNV to OS. Thus, potentially, vulnerable neurons even
under normal conditions are under elevated levels of
stress. The increases in OS resulting from the aging process
or from the onset of a neurodegenerative disease may shift
the balance between stress and cell defense mechanisms
and cause these neurons to die more readily than resistant
neurons. The lack of energy reserves would directly com-
promise the defensive responses of neurons vulnerable to
OS and increase the probabilities of neuronal injury
under conditions of OS. Therefore, potentially useful
approaches to protecting vulnerable neurons during aging
or in disease states, such as Alzheimer's disease, would be
those that are focused on decreasing endogenous levels of
OS, increasing energy metabolism, or enhancing some of
the cell defense processes that we found to be up-regu-
lated in vulnerable neurons.
Methods
Primary neuronal cultures and OS induction
Dissociated cerebral cortex and CbG neuron cultures were
established as described before [63-65]. All animal proce-
dures were performed in accordance with guidelines
established by the University of Kansas IACUC. For prep-
arations of cortical neuron cultures, the cortical lobes
from 18-day old Sprague Dawley fetuses were dissected
and cells dissociated by gentle trituration with trypsin and
harvested by centrifugation. Cortical cells were re-sus-
pended in fresh DMEM/F-12 with 10% fetal calf serum
(FCS), plated at densities ranging from 0.3 to 3 × 106 cells/
35 mm dish, coated with poly-D-lysine, and after 24 h, the
FCS-containing medium was replaced by a defined
medium with DMEM/F12 containing N2 supplements,
KHCO3 (15 mM), and 20% glial conditioned medium.
CbG neurons were prepared from 7–8 day old Sprague
Dawley pups. The dissociated cells were re-suspended in
Krebs-Ringer-buffered medium. They were then treated
with trypsin (50 μg/ml) and subsequently trypsin inhibi-
tor and DNase (80 μg/ml), plated at densities ranging
from 0.3 to 3 × 106 cells/35 mm dish (coated as above)
and maintained in basal Eagle's medium supplemented
with 10% FCS, 25 mM KCl, 2 mM glutamine, and 100 μg/
ml gentamicin. Growth of glial cells was inhibited by the
addition of 10 μM cytosine arabinoside. These cultures
were maintained at 37°C in ambient air mixed with 5%
CO2.
OS was induced by exposing primary cortex and CbG neu-
rons to increasing concentrations of paraquat (1,1'-dime-
thyl-4,4'-bipyridynium dichloride; 0–100 μM). Neurons
plated at 6 × 105 cells/35 mm dish were exposed to freshly
prepared paraquat added to the culture medium. After 24
h, neuronal viability was determined by the calcein AM
and propidium iodide (PI) labeling method [64]. The
medium was removed, replaced with 1 ml PBS containing
150 nM calcein AM and 20 μM PI for 30 min, after which
the cells were rinsed with PBS and visualized in a Nikon
fluorescence microscope. Viability was determined by
counting the number of green (alive) and red (dead) cells.
Neurons were classified as vulnerable if after treatment
their survival rate dropped below 40%.
Neuronal cultures under different O2 tension
To test the effects of O2 tension on CbG and cortical neu-
rons, primary neuron cultures established in the same way
as described above were maintained in either 5% or 20%
O2, in 90% or 75% N2, respectively, and in a constant 5%
CO2 atmosphere. Cell viability was measured by the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) reduction assay [66]. The assay was per-
formed by incubating neuronal cultures with MTT (0.5
mg/ml) for 4 h, solubilizing the formazan crystals formed
by the addition of an equal volume of 0.04 N HCl in iso-
propanol, sonicating the samples (2 min), and measuring
the absorbance at 570 nm. Background absorbance was
determined in cells pre-treated with iodoacetamide (10
mM), an inhibitor of succinate dehydrogenase.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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Biochemical analyses
For immunoblot studies, proteins were extracted from pri-
mary neurons 24 h after exposure to either paraquat or
buffer. Cells were lysed in 3 mM Tris-Cl, pH 8.0, contain-
ing 10 μl/ml of a protease inhibitor cocktail (Calbiochem,
San Diego, CA, USA) and the extracted proteins were sep-
arated by SDS-PAGE, transferred to PVDF membranes,
and probed with antibodies to cytochrome P450 reduct-
ase (1:200) (Nventa, San Diego, CA, USA), Cu/Zn-super-
oxide dismutase (SOD1) (1:1000) (Chemicon, Temecula,
CA, USA), Mn-SOD (SOD2, 1:1000) (Stressgen, Victoria,
Canada), and glutathione peroxidase 1 (GPX1, 1:500)
(Cortex Biochem, San Leandro, CA, USA). Equal amounts
of protein sample were loaded into each lane of SDS-
PAGE gels. Incubation with alkaline phosphatase-conju-
gated secondary antibody (1:1000) and color develop-
ment were as described [67]. Immunoblots were scanned
and densitometric analyses performed using Photoshop
5.0.
The levels of cellular ATP were measured using the ATP
Determination Kit (Molecular Probes, Carlsbad, CA, USA)
according to the manufacturer's instructions. The assay is
based on the generation of light by the ATP-dependent
reaction between luciferin and luciferase. The reaction
mixture in a final volume of 100 μl contained: 25 mM Tri-
cine buffer, pH 7.8, 0.1 mM EDTA, 0.5 mM luciferin, and
1.25 μg/ml luciferase. The reaction was initiated by the
addition of 10 μl of neuronal lysate prepared from control
and paraquat-treated cells, and the resultant biolumines-
cence (emission maximum 560 nm) measured in a lumi-
nometer. The concentration of cellular ATP was calculated
by a standard curve generated using known concentra-
tions of exogenous ATP.
Organotypic brain slice cultures and induction of OS
Two types of brain slice preparations were employed in
the studies: acute slice preparations from adult rat brains
and organotypic slice cultures from newborn rats. The
acute slice preparations were obtained from 3 mo-old
male rats, whereas the organotypic slice cultures were
established from 10-day old male rats [20,21,68]. For the
organotypic cultures, slices (300 μm thick) of hippocam-
pus, cerebellum, and cerebral frontal cortex were prepared
and maintained in culture for one week in 50% MEM,
25% Hanks' balanced salt solution, and 25% heat-inacti-
vated horse serum, plus 4.5 mg/ml glucose, 1 mM
glutamine, and 20 ml/L penicillin-streptomycin. The cul-
ture medium was removed 24 h prior to treatment with
paraquat and was replaced with serum-free medium.
Slices were either treated with 100 μM paraquat for 1 h
(OS) or buffer (controls). Neuronal death was determined
at 24 h after initiation of treatment by staining with PI. PI
was added to the treatment medium at a final concentra-
tion of 5 μg/ml. PI uptake was used to monitor cell death
since it is excluded from live cells. Fluorescence from the
PI staining was excited at 515–560 nm using a Zeiss
microscope fitted with rhodamine filter. Fluorescence as
well as visible-light (to visualize the whole area) images
were captured, and the percentage of dead neurons was
calculated. For the acute slice preparations, the slices from
the same brain regions as those used for organotypic cul-
tures were incubated in serum-free medium (described
above) for 2 h to allow for recovery from the dissection.
Subsequent paraquat treatment and estimation of cell
death by measuring PI uptake, were performed the same
as for the above organotypic cultures.
Cryosectioning and laser capture microdissection (LCM)
An optimized protocol [69] from Arcturus (Mountain
View, CA, USA) was followed for LCM. Six-months-old
Fisher 344/BN F1 rats that were not subjected to any prior
treatment were sacrificed, the brain dissected and imme-
diately frozen in liquid N2, and cryosections (8 μm thick)
obtained. In order to preserve RNA quality, frozen sec-
tions were quickly stained with Arcturus HistoGene LCM
Frozen Section Staining Kit. The Arcturus PixCell® IIe Laser
Capture Microdissection System was used for capturing
the cells. The four populations of target neurons were col-
lected from the hippocampal CA1 and CA3 regions, the
CbG cell layer, and the frontal cortex (layers IV-VI).
RNA extraction and GeneChip hybridization
Total RNA was extracted from the microdissected neurons
with the Arcturus PicoPure RNA isolation kit. Three repli-
cate samples representing each of the four neuronal pop-
ulations from each animal were obtained. The quality of
the RNA samples was checked with Agilent Bioanalyzer
2100 with RNA 6000 Pico Chips (Agilent Technologies,
Santa Clara, CA, USA). For GeneChip target preparation
with signal amplification, the GeneChip Two-Cycle cDNA
Synthesis Kit from Affymetrix (Santa Clara, CA, USA) was
used according to the manufacturer's instructions. The
Affymetrix Rat Expression 230A (RAE230A) oligonucle-
otide arrays containing 14,280 Unigene clusters were used
for the hybridization at 45°C for 16 h. Subsequent wash-
ing and staining steps were performed on an Affymetrix
GeneChip System running GeneChip Operating Software
(GCOS, ver 1.1.1). In order to minimize experimental var-
iability, all steps throughout the entire process, from cry-
osectioning to array data collection, were performed by
the same investigator. The microarray data generated from
all chips met the quality control criteria set by Affymetrix,
including low background and noise, positive detection
of QC probesets such as bioB, percentage of genes called
present in normal range (generally between 40–60%),
similar scaling factors across all chips, and 3'/5' ratio. All
microarray data were deposited in NCBI's Gene Expres-
sion Omnibus [70], with series accession number
GSE7139.BMC Neuroscience 2009, 10:12 http://www.biomedcentral.com/1471-2202/10/12
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GeneChip data analysis
The microarray data generated from GCOS, scaled to the
same signal intensity of 500, were imported to Gene-
Spring (version 7.2) (Agilent Technologies, Santa Clara,
CA, USA). In GeneSpring, the data were normalized on a
Per Chip (to 50th percentile) and Per Gene (to median)
basis. Gene Tree and PCA were subsequently conducted to
examine the reproducibility of samples from each brain
region. Both analyses were based on all probesets on the
array and Pearson correlation was used to measure simi-
larity.
For identification of differentially expressed genes
between vulnerable and resistant neurons, genes showing
expression (i.e., called "present" by GCOS) in at least two
thirds of all samples were selected as candidate genes,
while the rest were filtered out from further analysis. For
subsequent data analysis, samples from hippocampal
CA1 and CbG neurons were classified as the vulnerable
group (VUL), and those from CA3 and cortex neurons as
the resistant group (RES). In order for a gene to be identi-
fied as differing significantly in expression between the
two groups of neurons, two criteria had to be met: 1) aver-
age VUL/RES ratio of gene expression had to be either ≥1.5
or ≤0.667, i.e., genes had to have at least a 1.5-fold higher
expression in the VUL over RES, or a 1.5-fold higher
expression in the RES over VUL group; and 2) differential
gene expression had to reach statistical significance of P
0.05 in paired t-test statistical comparisons. Genes fulfill-
ing both criteria were plotted in a volcano plot. Multiple
testing corrections were based on the Benjamini and
Hochberg False Discovery Rate approach [71].
Genes showing significantly higher expression in VUL or
RES neuronal populations were subjected to further com-
parative analyses of their overall biological functions. GO,
Biological Pathway and gene networking analyses were
used to uncover their functional profiles. Comparative
analyses of the biological functions of differentially
expressed genes in VUL vs. RES neurons were conducted
using IPA (Ingenuity Systems, Mountain View, CA, USA).
For these analyses, all differentially expressed genes that
were associated with specific biological functions in the
Ingenuity Pathways Knowledge Base were considered.
Fischer's exact test was used to calculate a P value deter-
mining the probability that each biological function
assigned was due to chance alone.
For GO and Biological Pathway analyses, the lists of
probesets identified to be differentially expressed between
the VUL and RES groups were fed into MAPPFinder, a
component of GenMAPP (Gene Map Annotator and Path-
way Profiler, version 2.0) [29]. The gene and GenMAPP
databases used for the analyses were those of August
2006. Hypergeometric distribution was used in MAPP-
Finder. A Z score > 1.96 or < -1.96, and a permute P <
0.05, were considered to be statistically significant. Gene
networking analyses were performed using IPA on genes
related to cell energy generation. For these analyses, the
list of probesets for the genes was uploaded into IPA. Each
probeset was mapped to its corresponding gene object in
the Ingenuity Pathways Knowledge Base. These mapped
genes were overlaid onto a global molecular network
developed from information contained in the Ingenuity
Pathways Knowledge Base. A gene network was then algo-
rithmically generated based on their connectivity.
Real-time quantitative PCR
The same RNA samples used for the microarray analyses
were also used for the qPCR analyses. The RNA was first
reverse-transcribed to cDNA using oligo(dT) primers and
SuperScript™ II Reverse Transcriptase (Invitrogen,
Carlsbad, CA, USA). TaqMan® Gene Expression Assays
with the following Assay IDs (Applied Biosystems, Foster
City, CA, USA) were used: Rn00821759_g1 (Mt1a),
Rn00582365_m1 (Nefl), Rn00582417_g1 (Nfe2l2),
Rn00690607_m1 (Tf). TaqMan® Fast Universal PCR Mas-
ter Mix was employed for the amplification on an Applied
Biosystems 7500 Fast PCR System using Fast Mode. The
thermal cycling conditions were: 20 sec at 95°C (initial
denaturation), followed by 40 cycles of 95°C for 3 sec and
60°C for 30 sec. β-Actin (Actb, TaqMan® Gene Expression
Assay ID Rn00667869_m1) was used as endogenous con-
trol since its expression was found to be constant across
neuronal samples from the various regions. Quantifica-
tion of target genes was based on the relative standard
curve method [72].
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